UPDATE: Brean Capital Reiterates On Regeneron Pharmaceuticals On Increased Confidence
November 20, 2014 at 09:08 AM EST
In a report published Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ: ...